Allergies

Epinephrine 0.15 mg, 0.3 mg Injections Now Available for Anaphylaxis Treatment

Symjepi (epinephrine) 0.3mg and 0.15mg Injections are now available in retail pharmacies, according to Sandoz.

Kounis Syndrome: Prevalence and Epidemiology in the United States

The overall prevalence of Kounis syndrome in the United States is 1.1% among patients hospitalized for allergic/hypersensitivity/anaphylactic reactions, with a 7.0% rate of all-cause inpatient mortality.

IgE Reactivity to Cockroach Varies in Children With Asthma and Rhinitis

Immunoglobulin E reactivity varies significantly in children with asthma and rhinitis in allergic reactions to cockroaches.

Novel Topical Steroid Delivery System Shows Efficacy in Nasal Polyps

The fluticasone exhalation delivery system is a novel topical steroid delivery system that is an important adjunct therapy for sinonasal inflammatory disease.

Dupilumab Approved for Chronic Rhinosinusitis With Nasal Polyps

The Food and Drug Administration (FDA) has approved Dupixent (dupilumab; Sanofi and Regeneron) as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis.

Higher vs Standard Dose Steroid After Endoscopic Sinus Surgery for Nasal Polyposis

There is no significant increased benefit in using a higher-dose nasal steroid spray compared with the standard dose after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis.

OCuSOFT Lid Scrub Allergy Available for Ocular Seasonal Allergy Relief

OCuSOFT Inc. announced the availability of OCuSOFT Lid Scrub Allergy Eyelid Cleanser in pre-moistened pads for use in patients with allergic conditions.

Positive Results for Omalizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps

Genentech announced positive topline data from two phase 3 trials, POLYP 1 and POLYP 2, evaluating Xolair (omalizumab) for the treatment of adults with chronic rhinosinusitis with nasal polyps (CRSwNP) who have not adequately responded to intranasal corticosteroids.